Anuh Pharma Ltd Share Price

AGM Date: 19 Aug 2021

AGM 19/08/2021 Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Outcome of Board Meeting held today i.e. Friday, 21st May, 2021. Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), we are submitting herewith the Notice containing the business to be transacted at the 61st Annual General Meeting scheduled on Thursday, August 19, 2021 at 11.00 AM through Video Conferencing (VC) / Other Audio Visual Means (OAVM). (As Per BSE Announcement Dated on 23.07.2021) We wish to inform you that 61st Annual General Meeting of the Company has been duly convened and held on Thursday 19th August 2021 at 11.00 AM through Video Conferencing / Other Audio Visual Means. In this regard we are enclosing herewith the Voting Results in the prescribed format pursuant to the regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Voting Results in XBRL Format has also been uploaded on the BSE Listing Centre Portal. Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the copy of the proceedings of 61st Annual General Meeting of Anuh Pharma Ltd. held on Thursday 19th August 2021 at 11.00 AM through Video Conferencing / Other Audio Visual Means Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the copy of the proceedings of 61st Annual General Meeting of Anuh Pharma Ltd. held on Thursday 19th August 2021 at 11.00 AM through Video Conferencing / Other Audio Visual Means. Pursuant to the provisions of the Companies (Management and Administration) Amendment Rules 2015 and regulation 44 of the SEBI (listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the Consolidated Scrutinizers Report submitted by M/s Makarand M. Joshi & Co. Company Secretaries Scrutinizer for the 61st Annual General Meeting of the Company held on 19th August 2021. We wish to inform you that 61st Annual General Meeting of the Company has been duly convened and held on Thursday, 19th August, 2021 at 11.00 AM through Video Conferencing / Other Audio Visual Means. In this regard, we are enclosing herewith the Voting Results in the prescribed format, pursuant to the regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Voting Results in XBRL Format has also been uploaded on the BSE Listing Center Portal. Anuh Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 8/19/2021 6:59:28 AM)

AGM Date: 05 Aug 2022

AGM 05/08/2022 Please find enclosed herewith the copy of newspaper advertisement with respect to the Notice of 62nd Annual General Meeting of the Company through Video Conferencing (VC) / Other Audio Visual Means (OAVM), Book Closure and E-voting Information published in the Financial Express and Mumbai Lakshadeep on Tuesday, July 12, 2022 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement dated on 12.07.2022) Pursuant to the provisions of Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Annual Report of the Company for the financial year 2021-22 of the Company. (As Per BSE Announcement Dated 14.07.2022) Proceedings of the 62nd Annual General Meeting of the Shareholders of the Company. Pursuant to the provisions of Regulation 30 read with Schedule III and other applicable Regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), this is to inform you that at the 62nd Annual General Meeting (AGM) of the Company held on 5th August, 2022, the Shareholders have approved the re-appointment of Messrs. Jayantilal Thakkar & Co., Chartered Accountants, ((Firm Registration No.104133W), as Statutory Auditors of the Company or a second term of 5 (five) consecutive years from the conclusion of the 62nd AGM until the conclusion of the 67th AGM of the Company. We wish to inform you that 62nd Annual General Meeting of the Company has been duly convened and held on Friday, 5th August, 2022 at 4.30 PM through Video Conferencing / Other Audio Visual Means. In this regard, we are enclosing herewith the Voting Results in the prescribed format, pursuant to the Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Voting Results in XBRL Format has also been uploaded on the BSE Listing Centre Portal Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we are enclosing herewith the Consolidated Scrutinizer's Report submitted by M/s Sanjay Doshi & Asso., Company Secretaries, Scrutinizer for the 62nd Annual General Meeting of the Company held on 5th August, 2022. (As Per BSE Announcement Dated on 06/08/2022) Anuh Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 08/08/2022)

AGM Date: 18 Aug 2023

Fixes Book Closure For Annual General Meeting Fixes Record Date For Dividend and Annual General Meeting. Reg. 34 (1) Annual Report. Proceedings of the 63rd Annual General Meeting of the Shareholders of the Company Intimation under Regulation 30 of the SEBI (LODR)- Appointment/Reappointment of Directors. (As Per BSE Announcement Dated on 19/08/2023) Submission of Voting Results Under Regulation 44 of LODR. Submission of Scrutinizer Report. (As Per BSE Announcement Dated on 22.08.2023) We have enclosed, pursuant to the BSE email dated 06th April, 2024, the covering letter for clarification along with the Revised outcome of 63rd Annual General Meeting of the shareholders meeting dated 18th August, 2024 (As per BSE Announcement Dated on 08/04/2024)

AGM Date: 23 Aug 2024

Annual General meeting will be held on Friday, 23rd August, 2024; The Record date for the Dividend and Annual General Meeting is fixed and the same is enclosed herewith (As Per BSE Announcement dated on 30.07.2024) Outcome for the 64th Annual General Meeting of Anuh Pharma Limited held on Friday, 23rd August, 2024. (As Per BSE Announcement dated on 23.08.2024) Submission of Voting Results under Regulation 44 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on: 26/08/2024)

AGM Date: 22 Aug 2025

To consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2025, issue of Bonus Equity shares in the ration of 1:1 i.e. 1 (One) equity shares of ? 5.00/- each for every 1 (One) full paid-up equity share of ? 5.00/-, recommendation of Dividend for the Financial Year, 2024-25, subject to the approval of the members. In continuation with the earlier intimation being made on Exchange on 29/07/2025, please find attached the rectified covering letter along with Notice of 65th Annual General Meeting of the Company. (As Per BSE Announcement Dated on :29.07.2025) Outcome of the 65th Annual General Meeting of Anuh Pharma Limited held on Friday, 22nd August, 2025. (As Per BSE Announcement Dated on:22.08.2025) Submission of Scrutinizer Report and Voting Results for the 65th Annual General Meeting of the Company. (As Per BSE Announcement Dated on:26.08.2025)